Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3BCHECHRM1CHRM2CHRM3CHRM4CHRNA3CHRNA4CHRNB2CHRNB4ESR1ESR2GABRA1GABRB1GABRG2GBA1GHSRHRH1HTR1DHTR2AMAOBOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8UGCGrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | CA4 | P22748 | 3/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 3/20 | 0.33 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cadaverine Tartrate SCHEMBL6806779 | 0.96 | LMNA (0.48) | TSHRLMNACA4CYP3A4TDP1 | |
| Cadaverine Tartrate SCHEMBL5144678 | 0.92 | TSHR (0.47) | TSHRLMNACA4CYP3A4TDP1 | |
| Cadaverine Tartrate SCHEMBL119095 | 0.92 | TSHR (0.47) | TSHRLMNACA4CYP3A4TDP1 | |
| Cadaverine Tartrate SCHEMBL372570 | 0.92 | TSHR (0.47) | TSHRLMNACA4CYP3A4TDP1 | |
| Cadaverine Tartrate SCHEMBL813951 | 0.92 | TSHR (0.47) | TSHRLMNACA4CYP3A4TDP1 | |
| Cadaverine Tartrate SCHEMBL23855755 | 0.92 | TSHR (0.47) | TSHRLMNACA4CYP3A4TDP1 | |
| Cadaverine Tartrate SCHEMBL5141545 | 0.92 | TSHR (0.47) | TSHRLMNACA4CYP3A4TDP1 | |
| Cadaverine Tartrate SCHEMBL3591252 | 0.92 | TSHR (0.47) | TSHRLMNACA4CYP3A4TDP1 | |
| Cadaverine Tartrate SCHEMBL1985645 | 0.92 | TSHR (0.47) | TSHRLMNACA4CYP3A4TDP1 | |
| Cadaverine Tartrate SCHEMBL16527654 | 0.92 | TSHR (0.47) | TSHRLMNACA4CYP3A4TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260001060-A1 | HYDRODEOXYGENATION CATALYST AND PREPARATION METHOD THEREOF | BOEING CO (US) | 2026-01-01 | — | — | US | claimed |
| EP-4558266-A1 | HYDRODEOXYGENATION CATALYST AND PREPARATION METHOD THEREOF | The Boeing Company (US) | 2025-05-28 | — | — | EP | claimed |
| US-12237460-B2 | Composite material, preparation method thereof and lithium ion battery | ZHUHAI COSMX BATTERY CO., LTD. (CN) | 2025-02-25 | — | — | US | claimed |
| CN-118925761-A | Preparation method of bifunctional catalyst and application of bifunctional catalyst in high-density fuel synthesis | 天津大学 | 2024-11-12 | — | — | CN | claimed |
| CN-118416887-A | Application of metal-solid acid bifunctional catalyst in hydrocracking of polystyrene plastics | 南京工业大学 | 2024-08-02 | — | — | CN | claimed |
| CN-115672343-B | Hydrogenation catalyst, preparation method and application thereof | 中国石油化工股份有限公司 | 2024-05-24 | — | — | CN | claimed |
| CN-115007168-B | Preparation method of catalyst for converting short-chain fatty acid into hydrocarbon cleaning agent | 常州工学院 | 2024-03-01 | — | — | CN | claimed |
| CN-117463329-A | Hydrodeoxygenation catalyst and preparation method thereof | 波音公司 | 2024-01-30 | — | — | CN | claimed |
| WO-2024020474-A1 | HYDRODEOXYGENATION CATALYST AND PREPARATION METHOD THEREOF | THE BOEING COMPANY (US) | 2024-01-25 | — | — | WO | claimed |
| CN-113926447-B | Niobium-loaded carbon nano tube solid acid catalyst and preparation method and application thereof | 中国林业科学研究院林产化学工业研究所 | 2023-12-05 | — | — | CN | claimed |
| CN-108033933-B | Method for synergistically catalyzing one-step conversion of cellulose into 1, 4-anhydrosorbitol | 中国科学院广州能源研究所 | 2020-05-12 | — | — | CN | claimed |
| CN-106669655-B | Preparation method of solid acid catalyst for preparing 5-hydroxymethylfurfural from biomass | 华东理工大学 | 2020-01-10 | — | — | CN | claimed |
| CN-108620127-B | Catalyst for preparing 1, 5-pentanediol through hydrogenolysis of tetrahydrofurfuryl alcohol, preparation method and application thereof | 万华化学集团股份有限公司 | 2019-12-13 | — | — | CN | claimed |
| US-20150119236-A1 | OXIDATION CATALYST PREPARATION | ROHM & HAAS (US) | 2015-04-30 | — | — | US | claimed |
| EP-2858972-A1 | OXIDATION CATALYST PREPARATION | Rohm and Haas Company (US) | 2015-04-15 | — | — | EP | claimed |
| CN-104379549-A | Oxidation catalyst preparation | ROHM & HAAS | 2015-02-25 | — | — | CN | claimed |
| WO-2013184240-A1 | OXIDATION CATALYST PREPARATION | ROHM AND HAAS COMPANY (US) | 2013-12-12 | — | — | WO | claimed |
| CN-102998303-A | Detection method for determining contents of niobium and tantalum in steel by applying microwave digestion-ICP-AES (Inductively Coupled Plasma-Atomic Emission Spectrometry) | PANGANG GROUP JIANGYOU CHANGCHENG SPECIAL STEEL CO LTD | 2013-03-27 | — | — | CN | claimed |
| CN-102951683-A | Preparation and application of stable niobium precursor | UNIV EAST CHINA SCIENCE & TECH | 2013-03-06 | — | — | CN | claimed |
| US-4011296-A | RECOVERING URANIUM FROM NUCLEAR FUELS, SOLVENT EXTRACTION | GENERAL ELECTRIC COMPANY (US) | 1977-03-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260001060-A1 | HYDRODEOXYGENATION CATALYST AND PREPARATION METHOD THEREOF | SCO2, HAO2, TDO2 | TSHR 1588/4885LMNA 2827/4885CA4 846/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.